Acute administration of alprazolam has no effect on plasma homovanillic acid concentration in normal subjects

Research output: Contribution to journalArticlepeer-review

Abstract

Alprazolam has been suggested as an adjuvant to neuroleptic drugs in the treatment of schizophrenic patients. In an attempt to investigate whether alprazolam has an effect on dopaminergic neurotransmission, plasma homovanillic acid concentrations were measured for 24 h following a challenge with 3 mg of alprazolam or placebo in eight healthy subjects. Alprazolam had no effect on plasma homovanillic acid which may suggest that this agent is devoid of activity at the dopaminergic system in normal subjects.

Original languageEnglish
Pages (from-to)81-83
Number of pages3
JournalSchizophrenia Research
Volume5
Issue number1
DOIs
Publication statusPublished - 1991
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • (Schizophrenia)
  • Alprazolam
  • Plasma homovanillic acid

Fingerprint

Dive into the research topics of 'Acute administration of alprazolam has no effect on plasma homovanillic acid concentration in normal subjects'. Together they form a unique fingerprint.

Cite this